|
MechanismKCNJ13 gene modulators |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hubble Therapeutics, Inc.
0 Patents (Medical) associated with Hubble Therapeutics, Inc.
100 Deals associated with Hubble Therapeutics, Inc.
100 Translational Medicine associated with Hubble Therapeutics, Inc.